Home / mesothelioma / mesothelioma law firm / AstraZeneca heart drug in regulatory fast lane for wider use

Wednesday, April 29, 2015

AstraZeneca heart drug in regulatory fast lane for wider use

By Unknown
On

Channel News AsiaAstraZeneca heart drug in regulatory fast lane for wider useReutersLONDON, April 29 (Reuters) - U.S. regulators are to fast-track the review of a new use of AstraZeneca's heart drug Brilinta, meaning it could get the green light in the third quarter to be given to patients with a history of heart attacks. The drugmaker said on ...AstraZeneca (AZN) Granted Priority Review for BRILINTAStreetInsider.comall 8 news articles »

AstraZeneca heart drug in regulatory fast lane for wider use Rating: 4.5 Diposkan Oleh: Unknown

Subscribe to: Post Comments (Atom)
 

Top